Skip to main content
. 2021 Dec 30;18(1):65–70. doi: 10.3988/jcn.2022.18.1.65

Table 2. HRs of brain-cancer-specific mortality for all variables.

Variables Value (n=38,037) Brain-cancer-specific mortality (n=8,839) Unadjusted HR (95% CI) p
Age at brain cancer diagnosis (yr) 53.33±17.88 - 1.04 (1.03–1.04) <0.001
Sex <0.001
Male 16,791 (44.1) 4,671 (52.9) 1.50 (1.44–1.56)
Female 21,246 (55.9) 4,168 (47.2) 1.00 (reference)
Sleep disorder 17,714 (46.6) 3,995 (45.2) 0.92 (0.88–0.95) <0.001
Zolpidem use 11,823 (31.1) 2,827 (32.0) 1.01 (0.97–1.06) 0.564
Depression 16,030 (42.1) 3,456 (39.1) 0.83 (0.79–0.86) <0.001
Antidepressant use 18.573 (48.8) 3,721 (42.1) 0.71 (0.68–0.74) <0.001

Data are n (%) or mean±standard deviation values, except where indicated otherwise.

CI, confidence interval; HR, hazard ratio.